Robuta

https://www.uclahealth.org/clinical-trials/phase-3-study-gedatolisib-first-line-treatment-patients-with
clinical trial phasebreast canceruclastudygedatolisib
https://www.mdpi.com/2072-6694/15/15/3859
Bruton tyrosine kinase inhibitors (BTKi) and the BCL2 inhibitor venetoclax, with or without the anti-CD20 monoclonal antibody Obinutuzumab, represent the...
first line treatmentolderpatientscllnew
https://pubmed.ncbi.nlm.nih.gov/15277259/?utm_source=Firefox&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1jmC0p0kwOiCcoFdWNnDLt9teiWG5XXLdmSwZYr5NJoUy2Csb8&fc=20220328160043&ff=20220328160204&v=2.17.6
The combination of CPT-11/L-OHP is an active regimen as front-line treatment in AGC with a favourable toxicity profile and deserves further evaluation in...
combinationirinotecancptplusoxaliplatin
https://pubmed.ncbi.nlm.nih.gov/35440464/
ClinicalTrials.gov NCT03748134.
in combinationfirst linesintilimabversusplacebo
https://www.mdpi.com/2077-0383/12/9/3258
(1) Background: Whether standard bismuth quadruple therapy (BQT) is superior to concomitant therapy for the first-line treatment of Helicobacter (H.) pylori...
the firststandardbismuthquadrupletherapy